Larson Financial Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.43K Sell
426
-378
-47% -$6.6K ﹤0.01% 2655
2026
Q1
$15.4K Buy
804
+512
+175% +$11.1K ﹤0.01% 1991
2025
Q4
$6.42K Buy
292
+192
+192% +$3.46K ﹤0.01% 2359
2025
Q3
$1.21K Buy
100
+69
+223% +$934 ﹤0.01% 2861
2025
Q2
$578 Buy
31
+24
+343% +$475 ﹤0.01% 2821
2025
Q1
$134 Hold
7
﹤0.01% 2869
2024
Q4
$252 Hold
7
﹤0.01% 2377
2024
Q3
$297 Hold
7
﹤0.01% 2256
2024
Q2
$282 Buy
+7
New +$292 ﹤0.01% 1978

Other funds holding TNDM

Larson Financial Group's TNDM Position: Q2 2026 in Review

Larson Financial Group reduced its Tandem Diabetes Care (TNDM) stake by 47% in Q2 2026, selling an estimated $6.6K and leaving 426 shares worth $6.43K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.

Larson Financial Group first reported a position in TNDM in Q2 2024 and has held it in 9 quarters since. The position peaked at $15.4K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Larson Financial Group held 426 shares of Tandem Diabetes Care worth $6.43K as of Q2 2026.
  • Larson Financial Group sold 378 Tandem Diabetes Care shares in Q2 2026, an estimated $6.6K.
  • Tandem Diabetes Care made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2655 holding.
  • Larson Financial Group first reported a position in Tandem Diabetes Care in Q2 2024 and has held it in 9 quarters since.
  • Larson Financial Group's Tandem Diabetes Care position peaked at $15.4K in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.